EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE . (2026). Global Journal of Public Health Medicine, 8(1 (Ongoing), 216-227. https://doi.org/10.37557/33f44713